ESMO Real World Data and Digital Oncology Journal Citation Rate 2026
2949-8201
eISSN 2949-8201
Elsevier
GB
Q3 Quartile Open Access Verified Publisher
About ESMO Real World Data and Digital Oncology
ESMO Real World Data and Digital Oncology (ERWDDO) is a peer-reviewed academic journal covering Neoplasms. Tumors. Oncology. Including cancer and carcinogens, published by Elsevier in GB and in circulation since 2024, catalogued under ISSN 2949-8201 (e-ISSN 2949-8201). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 0.63 (Q3 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $3480 USD. It is indexed in DOAJ, among the databases we track. OpenAlex records 598 works and 448 citations, with an h-index of 10.
Authors typically receive a first decision in around 87 days.
ESMO Real World Data and Digital Oncology Citation Rate 2026 — In Context
ESMO Real World Data and Digital Oncology has a 2025 2-Year Citation Rate (OpenAlex) of 0.63, placing it in the Q3 quartile within the Neoplasms. Tumors. Oncology. Including cancer and carcinogens research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
As a fully open-access publication, ESMO Real World Data and Digital Oncology makes all articles freely available to readers for an Article Processing Charge of approximately $3480 USD. Average submission-to-decision turnaround is approximately 87 days.
Researchers looking to publish in ESMO Real World Data and Digital Oncology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare ESMO Real World Data and Digital Oncology against similar journals in the field, use our journal comparison tool.
Submission Tips for ESMO Real World Data and …
- Be prepared for a longer review cycle — decisions typically take around 87 days.
- Budget $3480 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Neoplasms. Tumors. Oncology. Including cancer and carcinogens. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How ESMO Real World … Compares
Compared against 4 journals in the same research areas.
| ISSN (Print) | 2949-8201 |
|---|---|
| ISSN (Online) | 2949-8201 |
| Publisher | Elsevier |
| Country | United Kingdom |
| Established | 2024 |
| APC / Cost | $3480 EUR |
| Review Speed | ~87 days to first decision |
| h-index | 10 |
| Total Works | 599 |
| Total Citations | 454 |
| 2-yr Mean Citedness | 0.70 (OpenAlex) |
| DOAJ | Listed |
In-depth profile & metrics
ESMO Real World Data and Digital Oncology is published by Elsevier, based in United Kingdom and in publication since 2024. It publishes open access with an article-processing charge of EUR 3480.
In our subject taxonomy, ESMO Real World Data and Digital Oncology is classified under Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
ESMO Real World Data and Digital Oncology is indexed in the DOAJ and OpenAlex. DOAJ listing confirms the journal's open-access policies have been independently vetted.
For prospective authors, ESMO Real World Data and Digital Oncology returns a first decision in about 87 days (longer for its field).
OpenAlex records 599 works that have together drawn 454 citations, giving the journal an h-index of 10; its most recent citation rate stands at 0.628; OpenAlex puts its two-year mean citedness at 0.70.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about ESMO Real World Data and …
Live Indexing Status
Updated July 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 0.628 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Works Published per Year (2023–2025)
Annual publication volume sourced from OpenAlex. Current year omitted (partial data).
Publication & citation history by year
| Year | Works published | Citations received |
|---|---|---|
| 2025 | 460 | 123 |
| 2024 | 61 | 267 |
| 2023 | 10 | 41 |
Journal at a Glance
Source: OpenAlex — refreshed daily.
Top Research Topics
The areas where ESMO Real World Data and … most frequently publishes, ranked by article volume. Click a topic to see the best journals for it.
Journal Metrics
Compare Journals
Compare ESMO Real World Data and Digi… against similar publications in its field:
Related Journals in Your Field
-
Journal of the Egyptian National Cancer Institute SpringerOpen IF 2.13
-
Cancer Research, Statistics, and Treatment Wolters Kluwer Medknow Publications IF 1.11
-
Endocrine Oncology Bioscientifica IF 0.75
-
Libri Oncologici University Hospital for Tumors IF 0.11
Explore More Journals
Metadata
Last updated: Jul 26, 2026
Updated by: system
Get weekly updates for Neoplasms. Tumors. Oncology. Including cancer and carcinogens journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.